Redefining cancer outcomes
Elephas (elephas.com) earns a Brand Analyzer score of 71 out of 100, placing it in the Brand-Ready tier among Healthcare brands, Technology brands. Among 2305 Healthcare brands analyzed, Elephas ranks in the 68th percentile (category average 68, leader 95). The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark. Dimension scores: Name Quality 97/100, Digital Presence 82/100, Visual Identity 100/100, Messaging Clarity 100/100, Trust Foundation 70/100, AI Discoverability 42/100, Brand Authority 28/100.
Elephas is a healthcare and technology company that predicts immunotherapy response using live tumor biopsies. Through functional profiling of living tissue, Elephas aims to help oncologists, clinical researchers, and pharmaceutical developers determine how cancer patients will respond to immunotherapy before treatment. The company's approach is intended to accelerate drug discovery and improve patient outcomes by providing accurate, biology-based predictions rather than relying solely on genomic or biomarker analysis.
| Brand Name | Elephas |
|---|---|
| Domain | elephas.com |
| Industry | Healthcare, Technology |
| Main Competitors | Champions Oncology, Tempus (76/100), Foundation Medicine (73/100), Guardant Health, Oncobiologics |
Moz Domain Authority 24/100 vs category average 29 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Elephas predicts immunotherapy response from live tumor biopsies to change how patients receive immunotherapy." (No meta description) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: og:title, Twitter cards, canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Social footprint: verified profiles on LinkedIn, Instagram, YouTube, GitHub; no detected presence on X (Twitter), Facebook - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Elephas scores 26/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Elephas has a weak AI-visibility profile at 26/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (45/100) and its weakest is visibility (17/100). It benefits from a Wikidata knowledge-graph entry and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, a low Moz Domain Authority of 24/100 and thin schema.org structured data.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Elephas's main competitors include Champions Oncology, Tempus (76/100), Foundation Medicine (73/100), Guardant Health, Oncobiologics. These companies compete in the Healthcare space for similar customers, offering comparable products or services.
Sources: Elephas official site
Elephas and Tempus are competitors in Healthcare. Brand Analyzer scores Elephas at 71/100 and Tempus at 76/100. They target overlapping audiences; the right choice depends on your specific needs and priorities.
Sources: Elephas official site
Popular alternatives to Elephas include Champions Oncology, Tempus (76/100), Foundation Medicine (73/100), Guardant Health, Oncobiologics. Each is an established option in the Healthcare space; the best fit depends on your specific needs, budget, and required features.
Sources: Elephas official site
Elephas has limited AI-search visibility, scoring 26/100 on Brand Analyzer's AI visibility composite (visibility 17, trust 22, recommendation 45). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Elephas official site
Elephas predicts immunotherapy response from live tumor biopsies. It uses functional profiling in living tissue to assess how a cancer patient's tumor will respond to immunotherapy treatments. This approach is designed to provide accurate predictions prior to or during treatment, helping clinicians and researchers make more informed decisions. The company also aims to accelerate drug discovery for pharmaceutical developers by providing biologically grounded insights into immunotherapy efficacy.
Sources: Elephas official site
Elephas scores 45/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Elephas official site
Elephas is a healthcare and technology company that operates in the field of oncology. It is focused on predicting how patients will respond to immunotherapy by analyzing live tumor biopsies. The company positions itself as a pioneer in functional immunotherapy response prediction, using functional profiling of living tissue as its core scientific approach. Its work sits at the intersection of clinical medicine, biological research, and technology, serving oncologists, clinical researchers, and pharmaceutical developers.
Sources: Elephas official site
Elephas can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Elephas official site
Elephas targets oncologists, clinical researchers, and pharmaceutical developers. Oncologists may use Elephas's functional profiling to inform treatment decisions for cancer patients receiving immunotherapy. Clinical researchers can leverage the platform to study immunotherapy responses in living tumor tissue. Pharmaceutical developers use Elephas to accelerate the discovery and development of new immunotherapy treatments by gaining more accurate biological predictions of drug efficacy.
Sources: Elephas official site
Elephas is known for its pioneering approach to functional immunotherapy response prediction using live tumor biopsies. Rather than relying on static genomic data, the company applies functional profiling in living tissue to predict how a patient's tumor will respond to immunotherapy. This methodology distinguishes Elephas within the oncology and precision medicine space, positioning it as an innovator in improving the accuracy of immunotherapy treatment decisions.
Sources: Elephas official site
Ranked closest to Elephas: Elemeno Health (71/100), Elation Health (71/100), Epicore Biosystems (71/100), Etiometry (71/100).
A step up - brands to learn from: Zipline (81/100), Zimmer Biomet (81/100).
Category leader: Dassault Systèmes (95/100).